‘AI is on trial’: Bond yields sink below 5% as investors look for safety
Investors are flooding back into Treasurys for safety to hedge the risks of more AI fallout in stock and credit markets. Source：MarketWatch
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.…
HSBC, Ant Digital test AI-agent payments using tokenized deposits
The technical trial showed how AI agents could discover services and make micropayments using HSBC’s tokenized deposits, with realtime settlement and risk…
This rare stock-market divide means an elevated chance of a big surge — or a deep plunge
There’s a huge and rare divergence between the twomonth returns of the Nasdaq and Dow Jones Industrial Average. Source：MarketWatch
The average U.S. stock is quietly getting crushed. Morgan Stanley says these ones are worth buying now.
Investors have fallen out of love with a large chunk of stocks, such as industrials, and Morgan Stanley sees an opportunity to pick up some names on the cheap.…
This $23 billion software deal was struck at a decade-low valuation, as AI winner takes out loser
Schneider Electric, the maker of electrical equipment that has thrived from the AI buildout, on Monday struck a $23 billion deal to buy an industrial design…
Canadian ‘crypto king’ set to represent himself at fraud trial
Aiden Pleterski was allegedly behind a crypto Ponzi scheme between 2021 and 2022 that resulted in a kidnapping and related criminal charges.…
Three reasons to stick with stocks despite rising yields, according to Barclays
Strategists at the bank recommend exposure to U.S. technology, media, telecommunications and industrial stocks. Source：MarketWatch
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
Viking Therapeutics is developing VK2735, a GLP1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring. Source：MarketWatch
Dow clinches its worst September start since 2008 as history repeats itself
The Dow Jones Industrial Average on Tuesday posted its worst performance during the first 10 days of September since 2008. Source：MarketWatch
Nasdaq, Boerse Stuttgart, others ask EU to remove or increase cap in tokenization trial
The coalition warned that the current limit is too low, noting some existing European projects already exceed it. Source：CoinDesk
Novartis’s failed trial for cholesterol drug leads to broad biopharma selloff
Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events. Source：MarketWatch